Dengue & COVID-19: A Comparison and the Challenges at Hand

The COVID-19 pandemic caused by SARS-CoV-2 spread across many countries between 2020 and 2022. The similarities in clinical presentation with other endemic diseases pose a challenge to physicians in effectively diagnosing and treating the infection. Approximately 129 nations have a risk of dengue infection, and more than 100 of those are endemic to dengue. During the COVID-19 pandemic, the number of dengue cases decreased in many countries owing to the isolation measures followed. However, the common clinical presentation between them has led to misdiagnosis. Both COVID-19 and dengue fever cause a surge in pro-inflammatory cytokines and chemokines, thus sharing a common pathophysiology. False positive serological test results also posed difficulty differentiating between COVID-19 and dengue fever. This review aims to compare the clinical features, pathophysiology, and immune response between dengue and COVID-19, to benefit public health management during the pandemic.

[1]  M. Mahtab,et al.  Dengue Infections during COVID-19 Period: Reflection of Reality or Elusive Data Due to Effect of Pandemic , 2022, International journal of environmental research and public health.

[2]  Jingbo Zhai,et al.  Coinfection of COVID-19 and Dengue: A Case Report , 2022, Frontiers in Medicine.

[3]  G. Ogg,et al.  Dengue and COVID-19: two sides of the same coin , 2022, Journal of biomedical science.

[4]  R. T. Sasmono,et al.  Movement dynamics: reduced dengue cases during the COVID-19 pandemic , 2022, The Lancet Infectious Diseases.

[5]  L. Daines,et al.  Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms , 2022, Pathogens.

[6]  Olivier Uwishema,et al.  Crimean-Congo haemorrhagic fever during the COVID-19 pandemic in Africa: Efforts, recommendations and challenges at hand , 2022, African Journal of Emergency Medicine.

[7]  Thamil Vaani Komarasamy,et al.  Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword , 2021, Frontiers in Immunology.

[8]  M. Lusida,et al.  Potential Misdiagnosis between COVID-19 and Dengue Infection Using Rapid Serological Test , 2021, Infectious disease reports.

[9]  Marcus Vinícius Magno Gonçalves,et al.  Diffuse skin rash in tropical areas: Dengue fever or COVID-19? , 2020, Anais Brasileiros de Dermatologia.

[10]  You-Wen He,et al.  A Potential Role of Interleukin 10 in COVID-19 Pathogenesis , 2020, Trends in Immunology.

[11]  H. Harapan,et al.  Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia , 2020, International Journal of Infectious Diseases.

[12]  T. Mak,et al.  An aberrant STAT pathway is central to COVID-19 , 2020, Cell Death & Differentiation.

[13]  N. Suganthan,et al.  Unusual Manifestations of Dengue Fever: A Review on Expanded Dengue Syndrome , 2020, Cureus.

[14]  R. Kolodny,et al.  Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Bernd Bodenmiller,et al.  A distinct innate immune signature marks progression from mild to severe COVID-19 , 2020, bioRxiv.

[16]  L. Zou,et al.  Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients , 2020, The Journal of infectious diseases.

[17]  Toshiaki Iba,et al.  The unique characteristics of COVID-19 coagulopathy , 2020, Critical Care.

[18]  Jie-yu Ye,et al.  Mechanisms involved in the development of thrombocytopenia in patients with COVID-19 , 2020, Thrombosis Research.

[19]  Brian D. Foy,et al.  The Endless Challenges of Arboviral Diseases in Brazil , 2020, Tropical medicine and infectious disease.

[20]  V. Wiwanitkit,et al.  COVID-19 can present with a rash and be mistaken for dengue , 2020, Journal of the American Academy of Dermatology.

[21]  A. Rothman,et al.  Immune-mediated cytokine storm and its role in severe dengue , 2017, Seminars in Immunopathology.

[22]  P. Young,et al.  Clinical and Laboratory Diagnosis of Dengue Virus Infection , 2017, The Journal of infectious diseases.

[23]  L. D. de Souza,et al.  Comparison of clinical and laboratory characteristics between children and adults with dengue , 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[24]  M. Guzmán,et al.  Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[25]  A. Veerman,et al.  Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. , 2001, The American journal of tropical medicine and hygiene.